Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial

IMPORTANCE: Long-acting injectable antipsychotics (LAIs) can potentially reduce hospitalization risk by enhancing medication adherence but are rarely considered for early-phase schizophrenia treatment. OBJECTIVE: To determine whether encouraging use of a LAI compared with usual care delays the time...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA psychiatry (Chicago, Ill.) Ill.), 2020-12, Vol.77 (12), p.1217-1224
Hauptverfasser:	Kane, John M, Schooler, Nina R, Marcy, Patricia, Correll, Christoph U, Achtyes, Eric D, Gibbons, Robert D, Robinson, Delbert G
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antipsychotic Agents - administration & dosage Antipsychotic Agents - pharmacology Antipsychotics Aripiprazole - administration & dosage Aripiprazole - pharmacology Clinical trials Comments Delayed-Action Preparations Female Follow-Up Studies Hospitalization Hospitalization - statistics & numerical data Humans Injections Male Medical treatment Mental health care Online First Original Investigation Outcome Assessment, Health Care Schizophrenia Schizophrenia - drug therapy Time Factors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!